Riskpilot← Back to searchSign inGet full accessCapio Nova AB
ABActiveOrg 5563291896Missunnavägen 7General medical practice activities · NACE 8621Est. 198873 employees
Revenue 2025
SEK 168,5M
+6% vs 2024
EBITDA margin
5.1%
+425% vs 2024
Equity ratio
8.6%
Financial strength
Net profit 2025
SEK 2,4M
73 employees
| Revenue | SEK 168,5M | +6% |
| EBITDA | SEK 8,5M | +425% |
| Net profit | SEK 2,4M | — |
| Total assets | SEK 32,1M | +44% |
| Equity | SEK 2,8M | +608% |
| Employees | 73 | — |
Legal name
Capio Nova AB
Org number
5563291896
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 juni 1988
Share capital
SEK 100 000
Employees
73 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med en av Lundskog, Åsa Maria Rahmquist, John Erik Gustaf Stark, Kent Patrik Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva läkarpraktik samt tillhandahålla läkartjänster, ävensom idka därmed förenlig verksamhet.
Address
Missunnavägen 7
Phone
+4641179680
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 80 172 | 106 832 | 163 879 | 114 279 | 142 839 | 149 565 | 159 025 | 168 472 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −1 742 | 3 264 | −3 996 | −4 525 | −11 794 | −9 320 | −1 775 | −4 594 | 1 625 | 8 528 |
| Depreciation & amort. | −676 | −513 | −322 | — | — | — | — | — | — | — |
| EBIT | −2 418 | 2 751 | −4 318 | −4 525 | −11 794 | −9 320 | −1 775 | −4 594 | 1 625 | 8 528 |
| Net financials | 9 | 2 325 | 35 | — | −41 | −114 | −3 626 | 206 | 368 | 434 |
| Profit before tax | 27 | 2 370 | 50 | −1 231 | 0 | 0 | 0 | 0 | 0 | 2 376 |
| Tax | −22 | −36 | −41 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 5 | 2 334 | 9 | −1 231 | 0 | 0 | 0 | 0 | 0 | 2 376 |
| Item | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 20 893 | 23 668 | 17 040 | 17 070 | 25 583 | 24 112 | 23 208 | 22 248 | 22 312 | 32 095 |
| Equity | 7 679 | 10 014 | 1 122 | 391 | 391 | 391 | 391 | 391 | 391 | 2 767 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 893 | 12 527 | 14 823 | 16 679 | 24 945 | 22 324 | 21 627 | 20 718 | 21 394 | 29 125 |
| Total debt | 11 893 | 12 527 | 14 823 | 16 679 | 24 945 | 22 324 | 21 627 | 20 718 | 21 394 | 29 125 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20152025
Equity ratio
8.6%
This company
38.2%
Market median
-77% vs market
20152025
Return on equity
85.9%
This company
18.4%
Market median
+367% vs market
20152025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20152025
Asset turnover
5.25×
This company
1.12×
Market median
+369% vs market
20152025
Debt / equity
10.60×
This company
0.62×
Market median
-1610% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-01-01 – 2020-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ÅM External Signatory | External Signatory | 2022 | — | — |
LE Chief Auditor | Chief Auditor | 2020 | — | — |
JE External Signatory | External Signatory | 2020 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
NE Chief Auditor | Chief Auditor | 2020 | — | — |
AR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 | — | — |
KP External Signatory | External Signatory | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Capio Närsjukvård AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Capio AB (publ)
Capio Nova AB Board members of Capio Nova AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Maria Lundskog | External Signatory | 0 companies |
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| John Erik Gustaf Rahmquist | External Signatory | 0 companies |
| Karin Maria Hult Steinberg | Chief Executive Officer | 0 companies |
| Nina Elisabeth Bergman | Chief Auditor | 0 companies |
| Ali Rezai | Deputy Chief Executive Officer | 0 companies |
| Kent Patrik Stark | External Signatory | 0 companies |
| Ulf Daniel Olsson | Chairman | 0 companies |
| Per Victor Stefan Bremberg | Board of Directors | 0 companies |
| Jarl Erik Martin Torstensson | Chairman | 0 companies |